Trevi Therapeutics Inc (NASDAQ:TRVI)

2.48
Delayed Data
As of Jan 27
 0.00 / 0.00%
Today’s Change
0.46
Today|||52-Week Range
4.68
+28.50%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Trevi Therapeutics Inc have a median target of 8.00, with a high estimate of 9.00 and a low estimate of 6.00. The median estimate represents a +222.58% increase from the last price of 2.48.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Trevi Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.10
Sales
$0.00
Reporting Date
Mar 22

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 16.67%
 
 
 
 
 
 
Growthannually 64.09%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.